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was administered to a sample ofmale university students aged 18-26 years. Patient
characteristics measured included education, race, major, marital/relationship
status and insurance status. Awareness regarding HPV and the vaccine, and atti-
tude towards willingness to get vaccinated, perceived risks of being infected with
HPV, and benefits of the vaccine weremeasured using a 5 point Likert scale. Coded
data were analyzed by conducting descriptive and correlation analysis using SAS
9.2. RESULTS: A total of 203 completed surveys were obtained. Mean (SD) age of
participants was 21.56 (2.44) years. Mean awareness scores were high for HPV
(3.89  1.34) and HPV vaccine (3.55  1.30). Mean attitude scores were somewhat
mixed for willingness to get vaccinated (2.89  1.10), benefit of vaccination (3.18 
1.04), and at risk of getting HPV (3.15 1.21). There was no significant co-relation-
ship between attitude and awareness variables. Willingness to get vaccinated was
negatively correlated with perceived risk (r0.15, p 0.05) and vaccination benefit
(r0.34, p0.05). CONCLUSIONS: Despite awareness regarding HPV and HPV vac-
cine a large proportion of the cohort was not willing to get vaccinated. This may be
due to the perception of not being at risk of getting infected and not having a clear
understanding of the benefits of vaccination.
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OBJECTIVES: Despite it=s importance, there are few published studies describing
the burden of pneumococcal disease in elderly population of developing countries.
The goal of this study is to estimate the burden of pneumococcal diseases inMexico
in people 50 years.METHODS: Mortality due to pneumonia, bacteremia, menin-
gitis and acute otitis media (AOM) in patients 50 years was extracted from Mex-
ican MoH official databases (2009 data, ICD-10 classification). Population structure
was extracted from the Mexican official source. Incidence and prevalence of pneu-
mococcal disease were extracted from published sources. Mortality was adjusted
according to the proportion of deaths attributable to pneumococcal disease (from
literature). Data were analyzed with DISMOD II software (to produce consistent
estimates for epidemiological parameters of pneumococcal disease). Presence and
type of comorbidities were taken in account: low risk: without comorbidities; mild
risk: congestive heart failure, valvular disease, valvular disorders, pulmonary hy-
pertension, peripheral vascular disease, hypertension, ischemic heart disease,
stroke, COPD, diabetes mellitus, chronic renal failure, chronic liver disease, use of
tobacco and alcohol abuse; high risk: comorbidities associated to HIV/AIDS, lym-
phoma, tumors, splenic disease and sickle cell anemia. RESULTS: For 2009 were
estimated 12,798 cases ofmeningitis, where 86% of patients had low risk and 13%had
moderate risk of comorbidity, mortality rate was 1.6 per 100,000 inhabitants. For out-
patient pneumonia 4,275 cases were estimated, 53% low risk and 46% mild risk. For
inpatient pneumonia 31,631 cases were estimated, 78% low risk and 21% mild risk,
mortality rate: 7.8 per 100,000. For AOM 9,817 cases were estimated (100% low risk).
Meanwhile, 611casesofbacteremiawereestimated, 98%had lowriskand2%hadmild
risk. CONCLUSIONS: The availability of reliable epidemiological parameters regard-
ingpneumococcal disease inMexicanpopulationover 50 could support theevaluation
of current prevention policies, as well as the design of more efficient ones.
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OBJECTIVES: Complicated skin and skin structure infections (cSSSI) are a common
reason for hospitalization. Inappropriate empiric therapy (IAET) for cSSSI prolongs
hospital stay. Patients with a mixed cSSSI (MSI, gram positives [GP] and gram
negatives [GM] present) are at an increased risk for receiving IAET. We set out to
examine the bacteriology and components of IAET coverage inMSI.METHODS:We
conducted a single-center retrospective cohort study of patients hospitalized April
2006 to December 2007 with a cSSSI. IAET was defined as failure to deliver an
antibiotic with in vitro activity against the offending pathogen(s) within 24 hours of
presentation. RESULTS: Of the 717 patients hospitalized with a cSSSI, 158 (22%)
received IAET; 68 (9.5%) had a MSI. Among all MSI, most frequently isolated patho-
gens were methicillin-resistant S. aureus (MRSA) (n23, 33.8%), Streptococcus sp.
(n22, 32.4%) and P. aeruginosa (n21, 30.9%). IAET was noted in 26 (38.2%) MSIs.
Both appropriate GP andGN coverageweremissing in 7 (26.9%) cases.While among
all MSIs treated with IAET Streptococcus sp. coverage was never missing, treatment
for MRSA was absent in 3 (11.5%) cases. Most frequently missing coverage was for
GN (n18, 69.2%), with P. aeruginosa untreated in 6 (23.1%). GP coverage was absent
in 15 (57.7%), most frequently for vancomycin-resistant Enterococcus sp. (VRE) (n9,
34.6%).CONCLUSIONS: In this single-center study, patientswith aMSIwere at high
risk for IAET. Coverage was more frequently left out for GN than for GP, with P.
aeruginosa and VRE frequently remaining untreated empirically.
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OBJECTIVES: In the absence of reminders, multi-dose vaccine completion rates for
adolescents and adults are low. Human papillomavirus (HPV) vaccine completion,
for example, is 32% among US adolescents. In the IMPACT trial (Improving Patient
Adherence through Clinic-initiated Text messages), we examine the efficacy of
automated text message-based reminders in improving series completion rates
among patients 9 years old who have begun, but not completed, one or more
multi-dose vaccine series: hepatitis B (HBV) or HPV.METHODS: In thismulti-center
randomized controlled trial, consenting participants (N334)were assigned during
a clinical visit to receive either 1) text message-based reminders before their next
dose, or 2) traditional appointment reminders. In group 1, text messages were
delivered to patients’ or parents’ cellular telephones using aweb-based application
that automatically sends text reminders prior to appointments dates entered by
clinical staff. We evaluated the association between treatment group and appoint-
ment attendance and vaccine series completion RESULTS: Among all participants,
HPV or HBV series completion within 6 months of enrollment was higher for those
receiving a text messages (39.8 % vs. 32.0%), but with meaningful effect modifica-
tion by age. Among adult patients, those who received a text were more likely to
complete their vaccine series for HPV or HBV (37.5% vs. 24.2%; risk ratio [RR] 1.55).
Among adult patients who initiated the HPV series alone, text messages doubled
the rate of vaccine completion (37.5% vs. 18.5%; RR 2.03). Textmessaging was not
effective for increasing series completion among adolescent participants. Text
messaging improved overall appointment attendance at 3 of the 4 clinical sites, but
the differenceswere not statistically significant.CONCLUSIONS: In this pilot study,
text messaging initiated by the clinical office demonstrated improved multi-dose
vaccine series completion among adult patients and showed promising trends for
reducing appointment no-show rates.
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OBJECTIVES: Research has consistently demonstrated the effectiveness of antiret-
roviral therapy (ART) in reducing HIV-related morbidity and mortality. Current
guidelines for the treatment of HIV identify specific combination regimens with
medications from two different drug classes. The objective of this study was to
assess compliance with these guidelines among treatment-naïve individuals.
METHODS: Mississippi Medicaid prescription claims data (1/2008 10/2011) were
analyzed for beneficiaries who met eligibility criteria: age 17, not pregnant, and
enrolled in Medicaid for at least three months prior to the index prescription date.
Beneficiaries were considered treatment-naïve and starting initial therapy if no
ART claims existed for at least threemonths prior to the first ART claim.Wedefined
a guideline-adherent ART regimen as use of a minimum of three drugs including
two nucleoside reverse transcriptase inhibitors (NRTIs) in combination with one
protease inhibitor (PI) or one nonnucleoside reverse transcriptase inhibitor (NNRTI)
between July 2008 and December 2010. Between January 2010 and November 2011,
a guideline-adherent ART regimen could also include two NRTIs in combination
with one integrase inhibitor. RESULTS: A total of 604 beneficiaries met inclusion
criteria. Between July 2008 and December 2009, 39.8% and 25.5% of beneficiaries
were on an NNRTI-based regimen and PI-based regimen, respectively. Addition-
ally, 4.4%metmore than one guideline simultaneously. Approximately 30.3%were
prescribed a medication regimen that was not in accordance with guidelines. Be-
tween January 2010 and October 2011, 38.8% and 24.1% of beneficiaries were on an
NNRTI-based regimen and PI-based regimen, respectively. Additionally, 5.3% met
more than one guideline simultaneously. Approximately 25.5% were prescribed a
medication regimen that was not in accordance with guidelines. CONCLUSIONS:
During the study period, the majority of beneficiaries were in accordance with
treatment guidelines for initial therapy for treatment-naïve patients withminimal
temporal changes across the three primary combination regimens.
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OBJECTIVES: Streptococcus pneumoniae is responsible for more than a million
deaths globally each year, most of them in the developing world. The burden of S.
pneumoniae infections is highest in children. Estimates in adult population are un-
common. Our objective was to determine the burden of disease, measured in dis-
ability adjusted life years (DALYs), associated with pneumococcus in adults (older
than 15 years of age) in Colombia in 2008.METHODS: Using different data sources
(national mortality records, official registries, published literature and local epide-
miological data) we estimated incidence, mortality and disability due to bacterial
pneumonia, bacterial meningitis and bacteremia of any cause for year 2008, and
the fraction of these that can be attributed to S. pneumoniae. We used Murray’s
standard methodology to estimate DALYs (including age-weighting and discount-
ing at 3%). RESULTS: There were 6488, 1276 and 452 deaths due to pneumonia,
bacteremia andmeningitis, respectively. Incidence rates for these same 3 diseases
(before adjusting for underreporting, that has been estimated in 65%) were 233,814;
999 and 960, respectively. A total of 63,463 DALYs are lost due to S. pneumoniae in
Colombians age 15 or over (55,362DALYs, 87%, due to premature death).Most of the
burden (51,848 DALYs, 81.7%) is due to pneumonia, followed by meningitis (9,241
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